Phase 1 pilot study of T antigen-presenting cells (T-APCs) in patients with Acute-lymphoblastic-leukaemia

Trial Profile

Phase 1 pilot study of T antigen-presenting cells (T-APCs) in patients with Acute-lymphoblastic-leukaemia

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 May 2017

At a glance

  • Drugs T antigen-presenting cells therapeutics-Juno/Seattle (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; First in man
  • Acronyms PLAT-03
  • Most Recent Events

    • 18 May 2017 New trial record
    • 09 May 2017 According to a Seattle Children's Hospital media release, Dr. Colleen Annesley, an oncologist at Seattle Children's will led this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top